Literature DB >> 12065364

Does acute organ dysfunction predict patient-centered outcomes?

Gilles Clermont1, Derek C Angus, Walter T Linde-Zwirble, Martin F Griffin, Michael J Fine, Michael R Pinsky.   

Abstract

BACKGROUND: Long-term patient-centered outcomes after acute illness may be associated with baseline health status, the development of acute organ dysfunction (AOD), or both. STUDY
OBJECTIVE: To determine whether AOD (occurring in the first 30 days) was independently associated with 90-day survival, functional status, and health-related quality of life (HRQL) after controlling for baseline health status in patients who were hospitalized with community-acquired pneumonia (CAP) and survived to day 30.
DESIGN: Prospective observational study.
SETTING: Four hospitals in Pennsylvania, Massachusetts, and Nova Scotia, Canada, between October 1991 and March 1994. PATIENTS: One thousand three hundred thirty-nine patients who were hospitalized with CAP.
INTERVENTIONS: Baseline and 90-day quality-of-life and functional status questionnaires. MEASUREMENTS AND
RESULTS: We determined the 90-day survival rate in all patients (n = 1,339) and the functional status and HRQL in subsets of 261 and 219 patients, respectively. AOD occurred in one or more organ system in 639 patients (47.7%) and in two or more organ systems in 255 patients (19.1%). In univariate analyses, greater AOD was associated with a higher mortality rate (p < 0.0001), a lower HRQL (p = 0.006), and lower functional status (p = 0.009) at 90 days. However, after adjusting for baseline HRQL, AOD was not associated with mortality (p = 0.47) or HRQL (p = 0.14) at 90 days and was only weakly associated with 90-day functional status (p = 0.02).
CONCLUSIONS: Although patients who develop AOD are at risk for late adverse outcomes, their risk is due predominantly to poor baseline status prior to illness and not to the organ dysfunction per se. Therefore, AOD does not appear to have significant long-term ramifications for patient-centered outcomes.

Entities:  

Mesh:

Year:  2002        PMID: 12065364     DOI: 10.1378/chest.121.6.1963

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

1.  Surviving intensive care: a report from the 2002 Brussels Roundtable.

Authors:  Derek C Angus; Jean Carlet
Journal:  Intensive Care Med       Date:  2003-01-21       Impact factor: 17.440

2.  The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis.

Authors:  Derek C Angus; Pierre-Francois Laterre; Jeff Helterbrand; E Wesley Ely; Daniel E Ball; Rekha Garg; Lisa A Weissfeld; Gordon R Bernard
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

3.  Do we need a new definition of sepsis?

Authors:  Manu Shankar-Hari; Clifford S Deutschman; Mervyn Singer
Journal:  Intensive Care Med       Date:  2015-02-03       Impact factor: 17.440

4.  Long term mortality following sepsis.

Authors:  Patrick John Kennelly; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2016-10

5.  Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate.

Authors:  Anders Perner; Nicolai Haase; Per Winkel; Anne B Guttormsen; Jyrki Tenhunen; Gudmundur Klemenzson; Rasmus G Müller; Anders Aneman; Jørn Wetterslev
Journal:  Intensive Care Med       Date:  2014-05-08       Impact factor: 17.440

6.  Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial.

Authors:  Sofie L Rygård; Lars B Holst; Jørn Wetterslev; Per Winkel; Pär I Johansson; Jan Wernerman; Anne B Guttormsen; Sari Karlsson; Anders Perner
Journal:  Intensive Care Med       Date:  2016-09-30       Impact factor: 17.440

Review 7.  Pharmacoeconomic implications of new therapies in sepsis.

Authors:  Kelly A Wood; Derek C Angus
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Bidirectional relationship between cognitive function and pneumonia.

Authors:  Faraaz Ali Shah; Francis Pike; Karina Alvarez; Derek Angus; Anne B Newman; Oscar Lopez; Judith Tate; Vishesh Kapur; Anthony Wilsdon; Jerry A Krishnan; Nadia Hansel; David Au; Mark Avdalovic; Vincent S Fan; R Graham Barr; Sachin Yende
Journal:  Am J Respir Crit Care Med       Date:  2013-09-01       Impact factor: 21.405

9.  Hospital readmission and healthcare utilization following sepsis in community settings.

Authors:  Vincent Liu; Xingye Lei; Hallie C Prescott; Patricia Kipnis; Theodore J Iwashyna; Gabriel J Escobar
Journal:  J Hosp Med       Date:  2014-04-04       Impact factor: 2.960

10.  Multiple organ dysfunction syndrome.

Authors:  A L Parke; P T Liu; D V Parke
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.